Skip to content
OpenCapital
Get started

DexCom DXCM Price / sales

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+91.0%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$27.49B-9.7%
Enterprise value$26.51B-10.8%
P/E29.5×-27.4×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0×0.0×
Current ratio1.9×+0.4×

Where this comes from

Calculated from DexCom’s reported figures.

market cap/total revenue=5×

Based on the most recent quarter.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's price / sales.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's price / sales?
DexCom (DXCM) reported price / sales of 5× in Q1 2026.
How has DexCom's price / sales changed year-over-year?
DexCom's price / sales decreased by 22.3% year-over-year, from 6.5× to 5×.
What is the long-term trend for DexCom's price / sales?
Over 4 years (2021 to 2025), DexCom's price / sales has grown at a -24.7% compound annual growth rate (CAGR), from 80.4× to 25.8×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.